DexCom, Inc.
DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time APIā¦ read more
Healthcare
Medical Devices
20 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$69.24
Price-0.66%
-$0.46
1Y
Price
Market Cap
$27.086b
Large
Price/Earnings 3y Avg5y Avg
38.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+34.4%
EBITDA Margin+23.5%
Net Profit Margin+47.9%
Free Cash Flow Margin+34.4%
EBITDA Margin+23.5%
Net Profit Margin+47.9%
Free Cash Flow MarginRevenue
$4.516b
+12.0%
1y CAGR+15.9%
3y CAGR+16.7%
5y CAGREarnings
$720.700m
+25.1%
1y CAGR+30.1%
3y CAGR+36.9%
5y CAGREPS
$1.80
+26.8%
1y CAGR+32.8%
3y CAGR+38.8%
5y CAGRBook Value
$2.726b
$7.500b
Assets$4.774b
Liabilities$2.521b
DebtDebt to Assets
33.6%
2.1x
Debt to EBITDAFree Cash Flow
$1.062b
+68.4%
1y CAGR+53.2%
3y CAGR+157.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company